FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2959577820> ?p ?o ?g. }

• W2959577820 endingPage "875" @default.
• W2959577820 startingPage "865" @default.
• W2959577820 abstract "The management of oligometastatic prostate cancer continues to stimulate as well as vex cancer professionals since the concept was raised more than two decades ago. The use of regular prostate-specific antigen (PSA) monitoring together with advances in imaging technology such as combined positron-emission tomography (PET)/computed tomography (CT) has enable earlier identification of potential initial spread of disease and recurrence. Recent systematic reviews and trials have supported the feasible and safe delivery of local ablative therapies for oligometastatic lesions with high local control rates and low morbidity. This is very appealing not only to the clinician but hugely to the patient; however, many questions remain as to whether this patient cohort is prognostically and clinically relevant as well as ultimately if local aggressive therapies can alter the natural history of disease progression and benefit these men. This overview examines the issues for identification, treatment, and management of men with oligometastatic prostate cancer. The management of oligometastatic prostate cancer continues to stimulate as well as vex cancer professionals since the concept was raised more than two decades ago. The use of regular prostate-specific antigen (PSA) monitoring together with advances in imaging technology such as combined positron-emission tomography (PET)/computed tomography (CT) has enable earlier identification of potential initial spread of disease and recurrence. Recent systematic reviews and trials have supported the feasible and safe delivery of local ablative therapies for oligometastatic lesions with high local control rates and low morbidity. This is very appealing not only to the clinician but hugely to the patient; however, many questions remain as to whether this patient cohort is prognostically and clinically relevant as well as ultimately if local aggressive therapies can alter the natural history of disease progression and benefit these men. This overview examines the issues for identification, treatment, and management of men with oligometastatic prostate cancer." @default.
• W2959577820 created "2019-07-23" @default.
• W2959577820 creator A5080362183 @default.
• W2959577820 date "2019-11-01" @default.
• W2959577820 modified "2023-09-27" @default.
• W2959577820 title "New concepts in prostate cancer management: the conundrum of managing oligometastatic disease in prostate cancer—through the looking glass darkly" @default.
• W2959577820 cites W1840588612 @default.
• W2959577820 cites W1891507428 @default.
• W2959577820 cites W1964305213 @default.
• W2959577820 cites W1984355291 @default.
• W2959577820 cites W2007849159 @default.
• W2959577820 cites W2022108741 @default.
• W2959577820 cites W2028578807 @default.
• W2959577820 cites W2036802856 @default.
• W2959577820 cites W2050146329 @default.
• W2959577820 cites W2052421497 @default.
• W2959577820 cites W2054074280 @default.
• W2959577820 cites W2069380387 @default.
• W2959577820 cites W2085278478 @default.
• W2959577820 cites W2093867637 @default.
• W2959577820 cites W2097930057 @default.
• W2959577820 cites W2100374144 @default.
• W2959577820 cites W2108824619 @default.
• W2959577820 cites W2114932214 @default.
• W2959577820 cites W2117792530 @default.
• W2959577820 cites W2127240958 @default.
• W2959577820 cites W2127407300 @default.
• W2959577820 cites W2131498353 @default.
• W2959577820 cites W2134190251 @default.
• W2959577820 cites W2137314791 @default.
• W2959577820 cites W2142138307 @default.
• W2959577820 cites W2148867458 @default.
• W2959577820 cites W2151630363 @default.
• W2959577820 cites W2154974136 @default.
• W2959577820 cites W2160166879 @default.
• W2959577820 cites W2166756664 @default.
• W2959577820 cites W2167331614 @default.
• W2959577820 cites W2214621962 @default.
• W2959577820 cites W2342476337 @default.
• W2959577820 cites W2470255787 @default.
• W2959577820 cites W2507354747 @default.
• W2959577820 cites W2529888262 @default.
• W2959577820 cites W2620798309 @default.
• W2959577820 cites W2664930764 @default.
• W2959577820 cites W2775321189 @default.
• W2959577820 cites W2807529025 @default.
• W2959577820 cites W2807579648 @default.
• W2959577820 cites W2897004478 @default.
• W2959577820 cites W2897236707 @default.
• W2959577820 cites W4240340450 @default.
• W2959577820 doi "https://doi.org/10.1016/j.crad.2019.05.003" @default.
• W2959577820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31176447" @default.
• W2959577820 hasPublicationYear "2019" @default.
• W2959577820 type Work @default.
• W2959577820 sameAs 2959577820 @default.
• W2959577820 citedByCount "10" @default.
• W2959577820 countsByYear W29595778202019 @default.
• W2959577820 countsByYear W29595778202020 @default.
• W2959577820 countsByYear W29595778202021 @default.
• W2959577820 countsByYear W29595778202022 @default.
• W2959577820 countsByYear W29595778202023 @default.
• W2959577820 crossrefType "journal-article" @default.
• W2959577820 hasAuthorship W2959577820A5080362183 @default.
• W2959577820 hasConcept C121608353 @default.
• W2959577820 hasConcept C126322002 @default.
• W2959577820 hasConcept C126838900 @default.
• W2959577820 hasConcept C143998085 @default.
• W2959577820 hasConcept C177713679 @default.
• W2959577820 hasConcept C19527891 @default.
• W2959577820 hasConcept C2775842073 @default.
• W2959577820 hasConcept C2776235491 @default.
• W2959577820 hasConcept C2779134260 @default.
• W2959577820 hasConcept C2780192828 @default.
• W2959577820 hasConcept C2781114028 @default.
• W2959577820 hasConcept C509974204 @default.
• W2959577820 hasConcept C71924100 @default.
• W2959577820 hasConceptScore W2959577820C121608353 @default.
• W2959577820 hasConceptScore W2959577820C126322002 @default.
• W2959577820 hasConceptScore W2959577820C126838900 @default.
• W2959577820 hasConceptScore W2959577820C143998085 @default.
• W2959577820 hasConceptScore W2959577820C177713679 @default.
• W2959577820 hasConceptScore W2959577820C19527891 @default.
• W2959577820 hasConceptScore W2959577820C2775842073 @default.
• W2959577820 hasConceptScore W2959577820C2776235491 @default.
• W2959577820 hasConceptScore W2959577820C2779134260 @default.
• W2959577820 hasConceptScore W2959577820C2780192828 @default.
• W2959577820 hasConceptScore W2959577820C2781114028 @default.
• W2959577820 hasConceptScore W2959577820C509974204 @default.
• W2959577820 hasConceptScore W2959577820C71924100 @default.
• W2959577820 hasIssue "11" @default.
• W2959577820 hasLocation W29595778201 @default.
• W2959577820 hasLocation W29595778202 @default.
• W2959577820 hasOpenAccess W2959577820 @default.
• W2959577820 hasPrimaryLocation W29595778201 @default.
• W2959577820 hasRelatedWork W1980245127 @default.
• W2959577820 hasRelatedWork W2400504790 @default.
• W2959577820 hasRelatedWork W2417976536 @default.
• W2959577820 hasRelatedWork W2736007806 @default.

• next